A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

Overview of attention for article published in Cancer Research, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 7,435 followers.

Tateishi et al identify hyperactive RelA/p65-hexokinase 2 signaling axis as potential therapeutic target for treatment of #CentralNervousSystem #lymphoma using specifically developed xenograft models. https://t.co/BHrN5TcdCt https://t.co/4YLGH31J4T

A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma https://t.co/pLuFtS1Aj1 https://t.co/sLDmI73HUM

A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma https://t.co/EiQ66GqJp6 https://t.co/ssum0o6s4l

RT @CR_AACR: Tateishi et al identify hyperactive RelA/p65-hexokinase 2 signaling axis as potential therapeutic target for treatment of #Cen…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.